Loading chat...
ID H0004
Bill
Status
3/5/2015
Primary Sponsor
Health and Welfare Committee
Click for details
AI Summary
HB 4 Summary
-
Amends Section 37-2701 to revise definitions related to controlled substances, including updates to "dispense," "manufacture," and "practitioner" definitions to clarify language and reflect board rule authority.
-
Modifies Section 37-2716 to permit practitioners registered under federal law to conduct Schedule I controlled substance research in Idaho upon registering with the state board and providing evidence of federal registration.
-
Updates Section 37-2717 to allow the board to consider federal registration restrictions when determining whether to register applicants, and permits federal registrants to conduct Schedule I research.
-
Expands Section 37-2718 disciplinary authority by allowing the board to "restrict" registrations in addition to suspending or revoking them, and clarifies procedures for referral of practice-related issues to state professional licensing boards.
-
Increases Section 37-2719 administrative fine authority from $1,000 to $2,000 per occurrence and allows the board to suspend registrations without an order to show cause in cases of imminent danger to public health or safety.
Legislative Description
Amends existing law to revise registration requirements, to permit federal registrants to conduct research; to revise language relating to registration and to allow consideration of DEA registration restrictions; to provide the Board of Pharmacy with additional disciplinary authority; to revise restrictions to actions that require an order to show cause and to revise the fining authority of the board; and to remove language relating to records of registration.
CONTROLLED SUBSTANCES
Last Action
Reported Signed by Governor on March 5, 2015 Session Law Chapter 25 Effective: 07/01/2015
3/5/2015